Vanguard Group’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $71.7M | Buy |
|
|||||
|
2025
Q2 | $28.8M | Buy |
|
|||||
|
2025
Q1 | $14.6M | Buy |
|
|||||
|
2024
Q4 | $10.2M | Sell |
|
|||||
|
2024
Q3 | $10M | Sell |
|
|||||
|
2024
Q2 | $8.03M | Sell |
|
|||||
|
2024
Q1 | $15.2M | Buy |
|
|||||
|
2023
Q4 | $77.7M | Buy |
|
|||||
|
2023
Q3 | $92.5M | Buy |
|
|||||
|
2023
Q2 | $106M | Buy |
|
|||||
|
2023
Q1 | $139M | Buy |
|
|||||
|
2022
Q4 | $161M | Buy |
|
|||||
|
2022
Q3 | $98.9M | Buy |
|
|||||
|
2022
Q2 | $19.1M | Buy |
|
|||||
|
2022
Q1 | $12.8M | Buy |
|